With four new COVID-19 autochthonous transmission events and a rise in the number of cases, the epidemiological situation in the province of Holguin is becoming more complex.

HAVANA, Cuba, Jun 18 (ACN) Since its approval on June 10 by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED), the Soberana-Pediatrics clinical trial is progressing satisfactorily, said its leader, Dr. Meiby de la Caridad Rodríguez González, director of Clinical Research and Impact Evaluation of the Finlay Institute of Vaccines.

More than four million doses of Cuban vaccine candidates have been applied so far in the country, said Dr. Maria Elena Soto Entenaza, head of the Department of Primary Health Care of the Ministry of Public Health (MINSAP).

Rosa Mendoza, 61, a resident of the town of El Cristo—about 20 km from the provincial capital—has been carrying the vaccine candidate Abdala in her body since June 11, as part of the health intervention organized in the country.

The province of Matanzas is suffering a fresh COVID-19 outbreak marked by five new events of local transmission, according to Ailuj Casanova Barreto, provincial director of Public Health.

The Digital Governance Observatory (OGD), a scientific and collaborative platform designed to evaluate, socialize and contribute to the development of this activity in Cuba, is conducting a survey to measure the level of citizen satisfaction with online services and procedures.

The province of Holguin is getting ready for a health intervention targeted on at-risk populations and groups, namely more than 500,000 residents, as part of the scheduled administration of the Cuban anti-COVID-19 vaccine candidates.

The general secretary of the Cuban Workers Confederation Ulises Guilarte stressed on Wednesday the Cuban government’s protection, along the unions and employers, of all workers amidst the COVID-19 pandemic.

Cuban vaccine candidates Abdala and Soberana Plus were integrated this week in the fight against COVID-19 in the province of Sancti Spíritus through a sanitary intervention mainly focused on local health workers.

The Cuban Center for Neuroscience (CNEURO) has developed Infantix, a neonatal screening system for the early detection of hearing and vision disorders in infants.

The Cienfuegos Botanical Garden (JBC) was selected as a sub-venue of the 13th International Convention on Environment and Development, to be held from July 5 to 9 of this year.

Scientists' forecasts, which predicted an increase in COVID-19 cases in the country in the month of June, are unfortunately being confirmed; and the number of daily sick people are expected to be higher in the coming days, as reality is indicating.

Gabriel Garcia (12) was the first Cuban child to have received the shot of the local COVID-19 candidate vaccine Soberana 02 as clinical trials began today at Havana’s Juan Manuel Marquez pediatric hospital.

With the beginning today of the health intervention in Old Havana, the Cuban capital expands the immunization of its population with the Abdala vaccine candidate and plans to extend it to all Havana territories.